Published in Autoimmun Rev on April 23, 2008
Toll-like receptors and B-cell receptors synergize to induce immunoglobulin class-switch DNA recombination: relevance to microbial antibody responses. Crit Rev Immunol (2010) 1.22
B cell TLRs and induction of immunoglobulin class-switch DNA recombination. Front Biosci (Landmark Ed) (2012) 0.99
Destruction of lymphoid organ architecture and hepatitis caused by CD4+ T cells. PLoS One (2011) 0.77
Natural antibody - Biochemistry and functions. Glob J Biochem (2011) 0.76
Antibody Repertoire Profiling with Mimotope Arrays. Hum Vaccin Immunother (2016) 0.75
Phase I/IIa study of cilengitide and temozolomide with concomitant radiotherapy followed by cilengitide and temozolomide maintenance therapy in patients with newly diagnosed glioblastoma. J Clin Oncol (2010) 3.05
Programmed death 1 signaling on chronic myeloid leukemia-specific T cells results in T-cell exhaustion and disease progression. Blood (2009) 2.20
Development of replication-defective lymphocytic choriomeningitis virus vectors for the induction of potent CD8+ T cell immunity. Nat Med (2010) 1.45
Elimination of chronic viral infection by blocking CD27 signaling. J Exp Med (2006) 1.32
Imatinib mesylate selectively impairs expansion of memory cytotoxic T cells without affecting the control of primary viral infections. Blood (2006) 1.08
Virus-induced polyclonal B cell activation improves protective CTL memory via retained CD27 expression on memory CTL. Eur J Immunol (2005) 1.03
CD27 signaling on chronic myelogenous leukemia stem cells activates Wnt target genes and promotes disease progression. J Clin Invest (2012) 0.99
CD4+ T cell help improves CD8+ T cell memory by retained CD27 expression. Eur J Immunol (2008) 0.98
CD27 signaling increases the frequency of regulatory T cells and promotes tumor growth. Cancer Res (2012) 0.98
From "magic bullets" to specific cancer immunotherapy. Swiss Med Wkly (2013) 0.97
Cytotoxic T cells induce proliferation of chronic myeloid leukemia stem cells by secreting interferon-γ. J Exp Med (2013) 0.96
CTL induction by cross-priming is restricted to immunodominant epitopes. Eur J Immunol (2009) 0.92
IL-33 signaling contributes to the pathogenesis of myeloproliferative neoplasms. J Clin Invest (2015) 0.89
Defective homing and impaired induction of cytotoxic T cells by BCR/ABL-expressing dendritic cells. Blood (2009) 0.84
Immunologic response to the survivin-derived multi-epitope vaccine EMD640744 in patients with advanced solid tumors. Cancer Immunol Immunother (2014) 0.84
Early clinical trial experience with vaccine therapies in non-small-cell lung cancer. Clin Lung Cancer (2008) 0.79
Decreased tumor surveillance after adoptive T-cell therapy. Cancer Res (2007) 0.78
Modulating CD27 signaling to treat cancer. Oncoimmunology (2012) 0.78
Destruction of lymphoid organ architecture and hepatitis caused by CD4+ T cells. PLoS One (2011) 0.77
Chronic myelogenous leukemia maintains specific CD8(+) T cells through IL-7 signaling. Eur J Immunol (2010) 0.77
[Extraordinary manifestation of a gastric carcinoma by leptomeningeal carcinomatosis and spinal metastasis]. Med Klin (Munich) (2007) 0.76
Interferons in hematopoiesis and leukemia. Oncoimmunology (2013) 0.75
Outcome of the antibody response: a question of antigen dose and distribution. Trends Immunol (2004) 0.75